Insiders Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Market Closed - Japan Exchange Other stock markets 02:32:15 2024-06-05 am EDT			5-day change	1st Jan Change
5,575 ^JPY	+2.61%		+1.46%	+43.98%

Jun. 04	Daiichi Sankyo Buys Back Shares Worth Over 29 Billion Yen in May	MT
Jun. 03	AstraZeneca Says Potential Breast Cancer Treatment Reduces Risk of Disease Progression by up to 38%	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

INTERVIEW - Hiroyuki Okuzawa, CEO of Daiichi Sankyo: Confident about the future thanks to the drug pipeline	23-06-07	MT
Daiichi Sankyo Company, Limited Announces Retirement of Noritaka Uji, Outside Director	23-05-16	CI
Daiichi Sankyo Posts 8% Decline in Fiscal Nine-month Attributable Profit on Growing Expenses; Rejigs Management Structure	23-01-31	MT
Daiichi Sankyo Company, Limited Appoints Hiroyuki Okuzawa as New President & COO Effective as of April 1, 2023	23-01-30	CI
Daiichi Sankyo Company, Limited Announces Executives Retirement, Effective as of June 21, 2021	21-05-13	CI
Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D with Effect from April 1, 2021	21-02-22	CI
Daiichi Sankyo Company, Limited Appoints New Corporate Officers, Effective April 1, 2021	21-02-21	CI
Daiichi Sankyo Company, Limited Announce Board Resignations	20-05-11	CI
Daiichi Sankyo Company, Limited Announces Changes to Members of the Board and Members of the Audit and Supervisory Board	19-05-10	CI
Daiichi Sankyo Company, Limited Announces Management Changes	19-04-25	CI
Daiichi Sankyo Company, Limited Announces the Management Changes	19-03-28	CI
Daiichi Sankyo Company, Limited Announces Executive Changes	19-02-22	CI
Daiichi Sankyo Company, Limited Announces New Group Corporate Officers Effective from April 1, 2019	19-02-21	CI
Daiichi Sankyo Company, Limited Appoints New Group Corporate Officers	17-02-24	CI
Daiichi Sankyo Company, Limited Announces Executive Changes	17-01-31	CI
Daiichi Sankyo, Inc. Appoints Leigh Ann Errico as Vice President of Human Resources for the U.S. Administrative and Commercial Group	16-08-23	CI
Daiichi Sankyo Company Limited Announces Management Changes	16-05-12	CI
Daiichi Sankyo Appoints Dr. Antoine Yver as Global Head, Oncology Research and Development	16-04-11	CI
Daiichi Sankyo Company, Limited Announces Appointment of New Group Corporate Officers, Effective April 1, 2016	16-02-23	CI
Daiichi Sankyo Company, Limited Announces Executive Appointments	14-09-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Insiders

Filters